KIORA PHARMACEUTICALS INC

KPRXReported to SECin USCIK 0001372514Filings at SEC EDGAR

KPRX is one of 2 listed share classes under this CIK; the filings below cover all of them.

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

3
Form 4 lines at KIORA PHARMACEUTICALS INC, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Lane Keith J.—Awardnothing paid55,000 sharesSep 17, 2026Lane Keith J.nothing paidAward · Sep 17Award55,000Sep 17, 2026
Tosca MelissaCFOAdministrative$2,423911 sharesJul 2, 2026Tosca MelissaCFO$2,423Admin · Jul 2Administrative911Jul 2, 2026
Strem Brian M.President and CEOAdministrative$4,9721,869 sharesJul 2, 2026Strem Brian M.President and CEO$4,972Admin · Jul 2Administrative1,869Jul 2, 2026